Detalles de la búsqueda
1.
No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination.
J Infect Dis
; 225(3): 413-421, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34609490
2.
Randomised controlled trial showed long-term efficacy, immunogenicity and safety of varicella vaccines in Norwegian and Swedish children.
Acta Paediatr
; 111(2): 391-400, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606114
3.
Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.
J Infect Dis
; 220(9): 1462-1468, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31299077
4.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30732648
5.
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
BMC Pediatr
; 16: 7, 2016 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26762528
6.
Clinical trials show similar safety outcomes including febrile convulsion rates for GSK's and Merck's measles-mumps-rubella (MMR) vaccines.
Hum Vaccin Immunother
; 19(1): 2188852, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988468
7.
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.
Vaccine
; 40(14): 2184-2190, 2022 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35232596
8.
A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.
Hum Vaccin Immunother
; 18(1): 1959148, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34435933
9.
Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries.
Hum Vaccin Immunother
; 17(10): 3747-3756, 2021 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181506
10.
Effectiveness of "Priorix" Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database.
Pediatr Infect Dis J
; 40(6): 590-596, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956757
11.
Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
Vaccine
; 39(25): 3445-3454, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736915
12.
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
Vaccine
; 39(10): 1534-1543, 2021 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077301
13.
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Vaccine
; 39(19): 2643-2651, 2021 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33858718
14.
Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children.
Vaccine
; 38(17): 3300-3304, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32184033
15.
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
J Pediatric Infect Dis Soc
; 9(2): 194-201, 2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849175
16.
Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
Vaccine
; 37(36): 5323-5331, 2019 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31345639
17.
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
Lancet Infect Dis
; 19(3): 287-297, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765242
18.
Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
Hum Vaccin Immunother
; 14(11): 2624-2631, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29902133
19.
One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Vaccine
; 36(3): 381-387, 2018 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29224964
20.
Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
Hum Vaccin Immunother
; 13(7): 1516-1522, 2017 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28481690